In the skin, BNP was found to sensitize transient receptor potential vanilloid 3 (TRPV3), resulting in enhanced Serpin E1 release, an itch-specific mediator with transcription levels positively correlated with the severity of human AD skin [63]. This evidence concerns the gene NPPB and Alzheimer disease.